Body iron stores and breast cancer risk in female atomic bomb survivors

Cancer Science

Volumn 102, Issue 12, 2011, Pages 2236-2240

  Stevens, Richard G ^a   Cologne, John B ^b   Nakachi, Kei ^b   Grant, Eric J ^b   Neriishi, Kazuo ^b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON;

ADOLESCENT; ADULT; ARTICLE; ATOMIC BOMB SURVIVOR; BREAST CANCER; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON STORAGE; OXIDATION; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY;

BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; FERRITINS; HUMANS; IRON; JAPAN; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WARFARE; NUCLEAR WEAPONS; RADIATION DOSAGE; RADIATION TOLERANCE; RISK; SURVIVORS;

EID: 81855194116     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02080.x     Document Type: Article

References (43)

1. Neriishi K, Stram DO, Vaeth M, Mizuno S, Akiba S. The observed relationship between the occurrence of acute radiation effects and leukemia mortality among A-bomb survivors. Radiat Res 1991; 125: 206-13.
2. Stevens RG, Morris JE, Anderson LE. Hemochromatosis heterozygotes may constitute a radiation-sensitive subpopulation. Radiat Res 2000; 153: 844-7.
3. Nelson JM, Stevens RG. Ferritin-iron increases killing of Chinese hamster ovary cells by X-irradiation. Cell Prolif 1992; 25: 579-85.
4. Knekt P, Reunanen A, Takkunen H, Aromaa A, Heliövaara M, Hakulinen T. Body iron stores and risk of cancer. Int J Cancer 1994; 56: 379-82.
5. Stevens RG, Graubard BI, Micozzi MS, Neriishi K, Blumberg BS. Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer 1994; 56: 364-9.
6. Herrinton LJ, Friedman GD, Baer D, Selby JV. Transferrin saturation and risk of cancer. Am J Epidemiol 1995; 142: 692-8.
7. Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 1996; 20: 553-66.
8. Hori A, Mizoue T, Kasai H et al. Body iron store as a predictor of oxidative DNA damage in healthy men and women. Cancer Sci 2010; 101: 517-22.
9. Stevens RG, Kalkwarf DR. Iron, radiation, and cancer. Environ Health Perspect 1990; 87: 291-300.
10. Liehr JG, Jones JS. Role of iron in estrogen-induced cancer. Curr Med Chem 2001; 8: 839-49.
11. Ferrucci LM, Cross AJ, Graubard BI et al. Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Br J Cancer 2009; 101: 178-84.
12. Moore AB, Shannon J, Chen C et al. Dietary and stored iron as predictors of breast cancer risk: a nested case-control study in Shanghai. Int J Cancer 2009; 125: 1110-7.
13. Kallianpur AR, Lee SA, Gao YT et al. Dietary animal-derived iron and fat intake and breast cancer risk in the Shanghai Breast Cancer Study. Breast Cancer Res Treat 2008; 107: 123-32.
14. Hong CC, Ambrosone CB, Ahn J et al. Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 1784-94.
15. Osborne NJ, Gurrin LC, Allen KJ et al. HFE C282Y homozygotes are at increased risk of breast and colorectal cancer. Hepatology 2010; 51: 1311-8.
16. Kondrashova TV, Neriishi K, Ban S et al. Frequency of hemochromatosis gene (HFE) mutations in Russian healthy women and patients with estrogen-dependent cancers. Biochim Biophys Acta 2006; 1762: 59-65.
17. Stevens RG, Morris JE, Cordis GA, Anderson LE, Rosenberg DW, Sasser LB. Oxidative damage in colon and mammary tissue of the HFE-knockout mouse. Free Radic Biol Med 2003; 34: 1212-6.
18. Kabat GC, Rohan TE. Does excess iron play a role in breast carcinogenesis? An unresolved hypothesis. Cancer Causes Control 2007; 18: 1047-53.
19. Shiono Y, Ikeda R, Hayashi H et al. C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan. Intern Med 2001; 40: 852-6.
20. Cologne JB, Sharp GB, Neriishi K, Verkasalo PK, Land CE, Nakachi K. Improving the efficiency of nested case-control studies of interaction by selecting controls using counter matching on exposure. Int J Epidemiol 2004; 33: 485-92.
21. Young RW, Kerr GD. Reassessment of the Atomic Bomb Radiation Dosimetry for Hiroshima and Nagasaki-Dosimetry System 2002. Hiroshima: Radiation Effects Research Foundation, 2005.
22. Pierce DA, Stram DO, Vaeth M. Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat Res 1990; 123: 275-84.
23. Langholz B, Borgan Ø. Counter-matching: a stratified nested case-control sampling method. Biometrika 1995; 82: 69-79.
24. Cologne J, Langholz B. Selecting controls for assessing interaction in nested case-control studies. J Epidemiol 2003; 13: 193-202.
25. Tokunaga M, Land CE, Tokuoka S, Nishimori I, Soda M, Akiba S. Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat Res 1994; 138: 209-23.
26. Preston DL, Ron E, Tokuoka S et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 2007; 168: 1-64.
27. Breslow NE, Storer BE. General relative risk functions for case-control studies. Am J Epidemiol 1985; 122: 149-62.
28. Land CE, Hayakawa N, Machado SG et al. A case-control interview study of breast cancer among Japanese A-bomb survivors. II. Interactions with radiation dose. Cancer Causes Control 1994; 5: 167-76.
29. Thomas DG. General relative-risk models for survival time and matched case-control analyses. Biometrics 1981; 37: 673-86.
30. Whittemore AS, McMillan A. Lung cancer mortality among U.S. uranium miners: a reappraisal. J Natl Cancer Inst 1983; 71: 489-99.
31. Walsh L. A short review of model selection techniques for radiation epidemiology. Radiat Environ Biophys 2007; 46: 205-13.
32. Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Rev 2009; 23: 95-104.
33. Cologne J, Izumi S, Shimizu Y, Preston D. Effect of comparison group on inference about effect modification by demographic factors in cohort risk regression. Jpn J Biometrics 2002; 23: 49-66.
34. Land CE, Tokunaga M, Koyama K et al. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990. Radiat Res 2003; 160: 707-17.
35. Stevens RG, Jones DY, Micozzi MS, Taylor PR. Body iron stores and the risk of cancer. N Engl J Med 1988; 319: 1047-52.
36. Cook JD. Adaptation in iron metabolism. Am J Clin Nutr 1990; 51: 301-8.
37. Zhang AS, Enns CA. Iron homeostasis: recently identified proteins provide insight into novel control mechanisms. J Biol Chem 2009; 284: 711-5.
38. McLaren CE, Barton JC, Eckfeldt JH et al. Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study. Am J Hematol 2010; 85: 101-5.
39. Greenland S. Tests for interaction in epidemiologic studies: a review and a study of power. Stat Med 1983; 2: 243-51.
40. Marshall SW. Power for tests of interaction: effect of raising the type I error rate. Epidemiol Perspect Innov 2007; 4: 4.
41. Land CE, Hayakawa N, Machado SG et al. A case-control interview study of breast cancer among Japanese A-bomb survivors. I. Main effects. Cancer Causes Control 1994; 5: 157-65.
42. Goodman MT, Cologne JB, Moriwaki H, Vaeth M, Mabuchi K. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors. Prev Med 1997; 26: 144-53.
43. Collaborative Group on Hormonal Factors in Breast Cancer. Alcohol, tobacco and breast cancer: collaborative reanalysis of individual data from 53 epidemiological studies, including 58, 515 women with breast cancer and 95, 067 women without the disease. Br J Cancer 2002; 87: 1234-45.